image_name,text_explanation
1,"Well to moderately differentiated hepatocellular carcinoma (Edmondson-Steiner grade II), invading the liver capsule, with secondary rupture, vascular tumor thrombus observed (MVI: M2), negative resection margin, surrounding liver tissue shows cirrhosis. Immunohistochemistry: AE1/AE3(+), Hepatocyte(+), Arginase-1(focal +), Glypican-3(+), CD34(capillarization), GS-6(+), CD31(capillarization), Vimentin(-), PD-1(-), PDL1(-)."
2,"Moderately to poorly differentiated hepatocellular carcinoma (Edmondson-Steiner grade IV), penetrating the liver capsule, satellite cancer nodules visible under the microscope (maximum diameter 0.2 cm), MVI: M1, no tumor in the resection margin. Chronic cholecystitis. Immunohistochemistry: Hepatocyte(+), GS-6(weak+), Arg1(+), GPC3(+), CK7(-), CK19(-), CDX-2(-), PD-1(-), PDL1(20%+, control is good)."
3,"Hepatocellular carcinoma (Edmondson-Steiner grade II-III). Immunohistochemistry: Hept1(+), Glypican-3(+), GS-6(+), Arg1(+), CD34(vessels+), CK19(focal+), CD10(-), Ki67(40%+), AE1/AE3(+), Vimentin(mesenchymal+)."
4,"Poorly differentiated carcinoma, consistent with small-cell hepatocellular carcinoma. Immunohistochemistry: AE1/AE3(+), Hep1(-), GS(-), Arg1(-), Glypican-3(-), CK19(-), CD34(vessels+), CD56(-), Syn(-), PD-1(-), PDL1(-), CK20(-), CK7(-)."
5,"Well-differentiated hepatocellular carcinoma. Immunohistochemistry: Hept1(+), Glypican-3(+), AFP(-), GS(+), Arg1(+), CD34(vessels+), Ki67(40%+), CK19(-), COX2(-), TTF-1(-)."
6,"Moderately differentiated hepatocellular carcinoma. Immunohistochemistry: Hepatocyte(+), AFP(weak+), GS-6(+), CD34(capillarization), Glypican-3(weak+), Arginase-1(+), PDL1(20%+), AE1/AE3(+), Vimentin(-)."
7,"(Right liver tumor) Hepatocellular carcinoma (Edmondson-Steiner grade II, trabecular type), close to the liver capsule, vascular tumor thrombus observed (MVI: M1) with satellite tumor nodule formation, no neural invasion, tumor thrombus visible in the hilar vein, cirrhosis around the tumor, tumor tissue close to the resection margin (approximately 0.1 cm). (Left liver tumor) Hepatocellular carcinoma (Edmondson-Steiner grade II, pseudoglandular type), close to the liver capsule, no neural invasion or vascular tumor thrombus, cirrhosis around the tumor, tumor tissue close to the resection margin. Immunohistochemistry: CD34(capillarization), Hepatocyte(+), Arg1(+), GS-6(+), Glypican-3(+), AE1/AE3(+), Vimentin(-)."
8,"(Left lateral lobe) Moderately differentiated hepatocellular carcinoma (Edmondson-Steiner grade II), no vascular tumor thrombus or neural invasion, MVI: 0, not involving the liver capsule, surrounding liver tissue shows cirrhosis. Immunohistochemistry: Hepatocyte(+), GS-6(+), Arginase-1(+), CD34(vessels+), Glypican-3(-), Ki67(15%+)."
9,"(Liver biopsy) Moderately differentiated hepatocellular carcinoma. Immunohistochemistry: AFP(-), Hepatocyte(+), Glypican-3(+), Arg1(+), GS(-), Ki67(30%+), CD34(vessels+), CDX-2(-), S-100P(-), CD10(-)."
10,"(Right liver lobe biopsy) Hepatocellular carcinoma (Edmondson-Steiner grade II). Immunohistochemistry: AE1/AE3(+), Vimentin(mesenchymal+), CK19(small bile duct+), GS-6(+), Hept1(+), Arg1(+), CD34(capillarization+), Glypican-3(+), Ki67(40%)."
11,"(Right liver lobe biopsy) Moderately differentiated hepatocellular carcinoma. Immunohistochemistry: AE1/AE3(+), Arginase-1(+), Glypican-3(+), Hepatocyte(+), CD34(capillarization+), CEA(-), CK19(-), CK20(-), PDL1(-), PD1(-), Vimentin(-)."
12,"(1. Right liver lobe biopsy) Well to moderately differentiated hepatocellular carcinoma (Edmondson grade III). Immunohistochemistry: AE1/AE3(+), Vimentin(+), Hept1(+), GS(+), Arg1(+), Glypican-3(+), CD34(capillarization), CEA(weak+), CK19(-), CK7(-)."
13,"(1. Right anterior liver) Hepatocellular carcinoma (trabecular and solid, Edmondson-Steiner grade III) with necrosis, 4 intramembranous vascular tumor thrombi around the tumor (MVI: M1, low risk), no involvement of the liver capsule, no neural invasion, no tumor at the resection margin. (2. Gallbladder) Chronic cholecystitis. Immunohistochemistry: Hepatocyte(+), Arginase-1(+), CD34(capillarization), CK19(-), Ki67(40%+), GS-6(+), Glypican-3(+)."
14,"(Right liver lobe biopsy) Moderately differentiated hepatocellular carcinoma. Immunohistochemistry: AE1/AE3(+), Hepatocyte(+), Arg1(+), Glypican-3(-), CD34(vessels+), GS-6(+), CK8/18(+), CD10(partial+), CK19(-), CK7(-)."
15,"(Right anterior liver) Moderately differentiated hepatocellular carcinoma (Edmondson-Steiner grade II-III), vascular tumor thrombus and satellite nodules observed (MVI: M2), no neural invasion, involving the liver capsule, no tumor at the resection margin, cirrhosis around the tumor. Immunohistochemistry: AE1/AE3(+), Hept1(+), Glypican-3(+), Arginase-1(+), GS-6(+), CD34(capillarization), Vimentin(-), Chronic cholecystitis."
16,"(Right liver lobe biopsy) Hepatocellular carcinoma (Edmondson-Steiner grade II-III). Immunohistochemistry: AE1/AE3(+), Hepatocyte(-), GS-6(focal+), Arg1(-), CD34(capillarization), Glypican-3(weak+), CK19(bile ducts+), CEA(-), CD10(small bile ducts+), CK8/18(+), CK7(-), CK20(-), Villin(+)."
17,"(Liver mass) Moderately differentiated hepatocellular carcinoma. Immunohistochemistry: AE1/AE3(+), Arg1(weak+), Hepatocyte(partial+), CK19(-), CD34(vessels+), GS-6(-), Ki67(50%+), Vimentin(-), CDX-2(-), Glypican-3(+)."
18,"(Right liver lobe biopsy) Moderately differentiated hepatocellular carcinoma. Immunohistochemistry: Hept1(+), Glypican-3(+), AFP(-), GS(+), Arg1(+), CD34(vessels+), Ki67(20%+), CK19(+), TTF-1(-), NKX2.2(-)."
19,"(Liver biopsy) Moderately differentiated hepatocellular carcinoma. Immunohistochemistry: Hepatocyte(-), Arginase-1(+), Glypican-3(-), GS-6(+), CEA(-), CK19(focal+), Ki67(approximately 40%+), CD34(capillarization), PDL1(-), PDL1(negative control, -)."
20,"(Right liver mass biopsy) Moderately differentiated hepatocellular carcinoma. Immunohistochemistry: AE1/AE3(focal+), Vimentin(mesenchymal+), GS-6(+), Arg1(+), Glypican-3(+), CD34(capillarization), Ki67(index 40%+), Hept1(+), CK19(-), CK7(-), PDL1(-)."
21,"(Right liver lobe biopsy) Well-differentiated hepatocellular carcinoma (Edmondson-Steiner grade II). Immunohistochemistry: Hept1(+), GS-6(+), Arginase-1(+), Glypican-3(+), CD34(capillarization), CK19(-), CK7(-), Ki67(50%+), PDL1(TPS: 5%)."
22,"(Liver biopsy) Well-differentiated hepatocellular carcinoma. Immunohistochemistry: Hepatocyte(+), GS-6(+), Arginase-1(+), Ki67(2%+), CD34(vessels+), Glypican-3(-), CD10(-), CK19(-), CDX-2(-), TTF-1(-)."
23,"(Right liver lobe biopsy) Small number of atypical cells remain at the necrotic tissue edge, suggestive of hepatocellular carcinoma. Immunohistochemistry: GS-6(+), Hepatocyte(+), Glypican-3(+), CD34(vessels+), CK7(focal+), CK19(-), CEA(-), Vimentin(-), Ki67(about 20%+), CD10(focal+)."
24,"(Right liver lobe biopsy) Moderately differentiated hepatocellular carcinoma (Edmondson-Steiner grade III). Immunohistochemistry: AE1/AE3(+), CD34(capillarization), Hepatocyte(+), GS-6(+), Arg1(+), CK19(-), PDL1(22C3: TPS=10% membrane+), CD10(-), Ki67(about 40%+)."
25,"(Right liver lobe biopsy) Moderately differentiated hepatocellular carcinoma, with regional necrosis. Immunohistochemistry: AE1/AE3(+), Hepatocyte(+), CEA(-), CD10(few+), CK8/18(+), GS-6(+), GPC3(+), Arginase-1(+), CD34(vessels+), Ki67(40%+)."
26,"(Right liver) Well to moderately differentiated hepatocellular carcinoma (Edmondson-Steiner grade II-III), no neural invasion or vascular tumor thrombus (MVI: M0), involving the liver capsule (not penetrated), no tumor at the resection margin. Immunohistochemistry: Hepatocyte(focal+), Arginase-1(scattered+), GS(+), Glypican-3(-), CD34(capillarization), CK7(-), CK20(-), PDL1(about 10%+), PDL1(negative control, -)."
27,"(Left liver lobe biopsy) Moderately differentiated hepatocellular carcinoma, with focal necrosis. Immunohistochemistry: AE1/AE3(+), Hepatocyte(partial+), CD10(-), CK8/18(+), GS-6(+), Arg1(partial+), CD34(capillarization), GPC3(+), PDL1(22C3: TPS ¡Ü 1%+)."
28,"(Liver) Tumor cells arranged in trabecular, nest, and pseudoglandular patterns, with mild atypia. Morphology and immunohistochemistry consistent with well-differentiated hepatocellular carcinoma (Edmondson-Steiner grade II), focal hemorrhage and cell degeneration, no capsule infiltration or intravascular tumor thrombus, resection margins clear, surrounding liver tissue shows significant chronic inflammation in the portal area. Immunohistochemistry: AE1/AE3(+), Hepatocyte(+), GS-6(+), Arginase-1(focal+), Glypican-3(+), CD34(capillarization+), CK19(-), CEA(-), CK8/18(+), CD10(+). Chronic cholecystitis."
29,"(Segment VII of liver) Hepatocellular carcinoma (Edmondson-Steiner grade II-III), no involvement of liver capsule, no neural invasion or intravascular tumor thrombus, no tumor at the resection margin. Immunohistochemistry: Hepatocyte(+), GS-6(+), Arginase-1(focal+), Ki67(15%+), Glypican-3(+), PD-1(-), PDL1(-), CD34(capillarization)."
30,"(Right liver biopsy) Moderately differentiated hepatocellular carcinoma. Immunohistochemistry: Hep(-), Gly(+), CD34(capillarization), GS-6(+), Arginase-1(+), AE1/AE3(-), Vimentin(-), PDL1(-)."
31,"(Right liver lobe biopsy) Hepatocellular carcinoma (Edmondson-Steiner grade II) with necrosis. Immunohistochemistry: AE1/AE3(+), Vimentin(mesenchymal+), Hepatocyte(+), Arg1(+), Glypican-3(+), GS(+), CD34(capillarization), CK19(-), Ki67(30%+), CD10(+)."
32,"(Right liver lobe biopsy) Hepatocellular carcinoma. Immunohistochemistry: AE1/AE3(+), Hepatocyte(+), Glypican-3(+), Arg1(+), CD34(vessels+), GS-6(+), Ki67(3%+), CDX-2(-), Vimentin(-), TTF-1(-)."
33,"(Liver tissue) Moderately differentiated hepatocellular carcinoma (Edmondson-Steiner grade III), with vascular tumor thrombus (MVI: M1), no neural invasion, no involvement of liver capsule, no tumor at resection margin, cirrhosis around the tumor. Immunohistochemistry: AE1/AE3(focal+), Vimentin(mesenchymal+), Hepatocyte(+), Glypican-3(focal+), Arginase-1(-), GS-6(+), CD34(capillarization+), CK19(-), CK7(-), Ki67(10%+)."
34,"(Right liver solid mass biopsy) Moderately differentiated hepatocellular carcinoma. Immunohistochemistry: Hepatocyte(+), Glypican-3(+), GS-6(+), Arginase-1(+), CD34(vessels+), CK7(-), AFP(-), CK19(-), PDL1(-). (Note: PD-L1 clone number: 22C3; VENTANA BenchMark Ultra)."
35,"(Left liver lobe biopsy) Small amount of moderately differentiated hepatocellular carcinoma. Immunohistochemistry: AE1/AE3(+), Hepatocyte(+), Glypican-3(+), GS-6(+), CD34(capillarization), CD10(+), Ki67(30%+), CK19(-), PDL1(-), PDL1(negative control, -). (Note: PD-L1 clone number: 22C3 VENTANA BenchMark Ultra). (Immunohistochemical results are laboratory data and may be influenced by environmental conditions, temperature, counting errors, and reagent batch numbers, so they are for reference purposes in treatment and prognosis evaluation)."
36,"(Right liver lobe biopsy) Small amount of well to moderately differentiated hepatocellular carcinoma with nodular cirrhosis. Immunohistochemistry: AE1/AE3(+), Vimentin(-), Glypican-3(+), Arginase-1(+), GS-6(+), Hept1(+), CD34(capillarization), PDL1(-), Ki67(30%+), PD1(-)."
37,"(Right liver lobe biopsy) Moderately differentiated hepatocellular carcinoma. Immunohistochemistry: AE1/AE3(+), CK8/18(+), Arginase-1(+), GS-6(+), CD34(vessels+), Hepatocyte(+), CD10(+), Glypican-3(-), CK19(-), Ki67(about 10%)."
38,"(1. Left lateral liver) Hepatocellular carcinoma (Edmondson-Steiner grade III), no neural invasion or vascular tumor thrombus, no involvement of liver capsule, resection margin near the tumor (about 0.1 cm from the margin). (2. Left medial liver) Hepatocellular carcinoma (Edmondson-Steiner grade III), vascular tumor thrombus observed (MVI: M1), no involvement of liver capsule, no tumor at the resection margin. (3. Gallbladder) Chronic cholecystitis. Immunohistochemistry: Hepatocyte(+), Glypican-3(+), GS-6(+), Arg1(+), CK19(-), CD34(capillarization)."
39,"(Right liver lobe biopsy) Well-differentiated hepatocellular carcinoma. Immunohistochemistry: Hepatocyte(+), Glypican-3(weak+), GS-6(+), Arg1(+), Ki67(5%+), CD34(vessels+), CK19(-), CDX-2(-), PAX-8(-), TTF-1(-)."
40,"(Left lateral liver biopsy tissue) Small amount of hepatocellular carcinoma. Immunohistochemistry: Glypican-3(+), CD34(vessels+), GS-6(+), PDL1(-), Hepatocyte(-)."
41,"(Liver biopsy) Well-differentiated hepatocellular carcinoma. Immunohistochemistry: Hepar-1(+), Arg1(+), GS-6(+), CD34(vessels+), Ki67(30%+), Glypican-3(-), PSA(-), TTF-1(-), CDX-2(-)."
42,"(Right liver) Well to moderately differentiated hepatocellular carcinoma (Edmondson-Steiner grade II-III), MVI: M0, no vascular tumor thrombus or satellite cancer nodules observed, involving the liver capsule (not penetrated), no tumor at the resection margin, surrounding liver tissue shows cirrhosis. Immunohistochemistry: Hepatocyte(+), GS-6(+), Arginase-1(+), Glypican-3(-), AFP(-), CK7(-), CK19(-), PDL1(-), CD34(capillarization)."
43,"(Right liver) Small amount of moderately differentiated hepatocellular carcinoma with large areas of necrosis. Immunohistochemistry: AE1/AE3(+), Hepatocyte(-), CD10(partial+), CD34(vessels+), CK8/18(+), GS-6(+), GPC3(-), Arg1(-), PDL1(22C3: TPS -)(control-)."
44,"(Liver biopsy) Hepatocellular carcinoma (Edmondson-Steiner grade II). Immunohistochemistry: Hepatocyte(+), GS-6(+), CDX-2(-), Glypican-3(+), CK19(-), CK7(-), CK20(-), Villin(+), SATB-2(-), Arg1(-)."
45,"(Right liver biopsy) Hepatocellular carcinoma. Immunohistochemistry: AE1/AE3(+), Vimentin(-), Hepatocyte(+), GPC3(+), CD34(capillarization), Arginase-1(+), GS-6(+), CK7(-), CK20(-), CK19(-)."
46,"(Liver) Hepatocellular carcinoma (Edmondson-Steiner grade II), no neural invasion or vascular tumor thrombus (MVI: M0), involving the liver capsule, no tumor at the resection margin, surrounding liver tissue shows cirrhosis. Immunohistochemistry: Hepatocyte(+), Glypican-3(+), GS(+), Arginase-1(+), Ki67(30%+), CD34(vessels+), AFP(-), CDX-2(-), S-100P(-), CD10(-)."
47,"(Liver biopsy) Moderately differentiated hepatocellular carcinoma with vascular tumor thrombus. Immunohistochemistry: AE1/AE3(+), Hepatocyte(+), CK7(-), CD10(+), CK8/18(+), GS-6(+), GPC3(+), Arginase-1(-), CD34(capillarization), PSA(-), P504S(+)."
48,"(Right liver nodule biopsy) Well to moderately differentiated hepatocellular carcinoma. Immunohistochemistry: Hepatocyte(+), Glypican-3(+), GS(+), Arginase-1(-), CD34(vessels+), Ki67(10%+), CDX-2(-), TTF-1(-), SMA(-)."
49,"(Right hemi-liver) Multiple (3) moderately differentiated hepatocellular carcinoma (Edmondson-Steiner grade III), MVI: M2, vascular tumor thrombus observed, no satellite cancer nodules, involving the liver capsule (not penetrated), no tumor at the resection margin. Chronic cholecystitis, no metastatic cancer in the gallbladder neck lymph node (0/1). Surrounding liver tissue shows cirrhosis. Immunohistochemistry: Glypican-3(+), GS-6(+), Arginase-1(+), Hepatocyte(-), AFP(-), CK7(-), CK19(-), PDL1(5%+), CD34(capillarization)."
50,"(Right liver biopsy) Moderately differentiated hepatocellular carcinoma. Immunohistochemistry: Hepatocyte(-), Arginase-1(focal+), Glypican-3(+), GS-6(+), CK20(-), CD10(bile ducts+), PDL1(-), CK7(weak+), CK19(+)."
51,"(Liver biopsy) Well-differentiated hepatocellular carcinoma. Immunohistochemistry: Hepatocyte(+), AE1/AE3(+), Vimentin(-), CK5/6(-), Arginase-1(+), GS(+), Glypican-3(+), CD10(-), CD34(-), Ki67(70%)."
52,"(Liver) Moderately to poorly differentiated hepatocellular carcinoma (Edmondson-Steiner II-III grade), with microsatellite nodules (MVI: M1), no invasion of vessels, nerves, or liver capsule, adjacent to resection margin, surrounding liver tissue shows cirrhosis. Immunohistochemistry: AE1/AE3(+), Hepatocyte(+), Glypican-3(+), GS-6(+), Arginase-1(+), CD34(capillarization), Syn(-), CD56(-), Vimentin(-), Ki67(40%+), PDL1(-)."
53,"(Liver biopsy) Hepatocellular carcinoma (Edmondson-Steiner grade II-III). Immunohistochemistry: Arginase-1(+), CD34(sinusoidal capillarization), Glypican-3(+), Hepatocyte(+), GS-6(+), Ki67(10%+), CK19(-), CK5/6(-), CD10(focal+), S-100(-)."
54,"(Right liver biopsy tissue) Well to moderately differentiated hepatocellular carcinoma. Immunohistochemistry: AE1/AE3(+), Vimentin(-), Hepatocyte(+), Glypican-3(+), CD34(capillarization), GS(+), Arg1(+), CK19(-), Arginase-1(+)."
55,"(Left liver biopsy) Moderately differentiated hepatocellular carcinoma with fibrous tissue proliferation and chronic inflammatory cell infiltration, scattered foci of tumor tissue. Immunohistochemistry: AE1/AE3(+), Hepatocyte(+), CD10(+), GS-6(+), GPC3(+), Arginase-1(focal weak+), LCA(inflammatory cells+), CK7(-), CK19(-), CD34(+)."
56,"(Right liver S6 biopsy) Small amount of poorly differentiated cancer at the edge of necrotic and fibrous tissue, consistent with hepatocellular carcinoma based on immunohistochemistry. Immunohistochemistry: AE1/AE3(+), Glypican-3(focal+), GS-6(+), Vimentin(-), Hepatocyte(-), CD34(-), CK19(-), CK7(-), CK20(-), PDL1(-)."
57,"(Right liver solid mass biopsy) Moderately differentiated hepatocellular carcinoma. Immunohistochemistry: AE1/AE3(+), Vimentin(-), Hep(+), Arg1(+), Glypican-3(+), CD34(capillarization), GS-6(+), PDL1(about 15%+)."
58,"(Liver) Moderately differentiated hepatocellular carcinoma (Edmondson-Steiner grade III) with regional necrosis and vascular tumor thrombus, involving the liver capsule (not penetrated), adjacent to the resection margin, cirrhosis surrounding the tumor. Chronic cholecystitis. No metastatic cancer in twelve lymph nodes (0/1). Immunohistochemistry: AE1/AE3(+), Hepatocyte(+), CEA(-), CD10(-), CD34(capillarization+), CK8/18(+), GS-6(+), GPC3(+), Arg1(focal+), PDL1(22C3: TPS 25% tumor cell membrane+)(control-)."
59,"(Left liver biopsy) Moderately differentiated hepatocellular carcinoma (Edmondson-Steiner grade III). Immunohistochemistry: AE1/AE3(+), Hepatocyte(+), Ki67(50%+), GS-6(+), Vimentin(-), Glypican-3(-), Arginase-1(-), CD34(-)."
60,"(Right liver) Hepatocellular carcinoma (Edmondson-Steiner grade II), no neural or vascular invasion (MVI=M0), no involvement of the liver capsule, adjacent to the resection margin. Immunohistochemistry: AE1/AE3(+), Vimentin(mesenchymal+), CK19(-), Hepatocyte(+), GPC3(+), Arg1(+), CD34(capillarization), GS(+)."
61,"(Right liver biopsy) Hepatocellular carcinoma (well-differentiated, Edmondson-Steiner I-II grade). Immunohistochemistry: Hepatocyte(+), Glypican-3(focally weak+), GS-6(+), CD34(capillarization), CD10(+), Ki67(5%+), Arg1(+), AE1/AE3(+), PDL1(CPS 0), PDL1(negative control, -)."
62,"(Right liver biopsy) Hepatocellular carcinoma (moderately differentiated, Edmondson-Steiner grade II). Immunohistochemistry: AE1/AE3(+), Hepatocyte(+), Glypican-3(+), Arginase-1(+), GS-6(+), CK19(-), CD10(-), CD34(+, capillarization), PDL1(CPS score=5; negative control, -)."
63,"(Left outer liver biopsy) Small amount of hepatocellular carcinoma. Immunohistochemistry: Hepatocyte(+), Glypican-3(+), GS-6(+), CD34(vascular+), Ki67(index 10%+), CK19(-), CEA(-), PDL1(-), PDL1(negative control: -), Arg1(+)."
64,"(Liver biopsy) Hepatocellular carcinoma (moderately differentiated). Immunohistochemistry: AE1/AE3(+), Hept1(+), Glypican-3(+), Arginase-1(+), GS(+), CD34(vascular+), Ki67(30%+), CD10(-), Vimentin(-), CDX-2(-)."
65,"(Right liver) Moderately differentiated hepatocellular carcinoma (Edmondson-Steiner grade II), satellite nodules visible under the microscope (MVI: M1), no nerve or liver capsule invasion, resection margin is negative, surrounding liver tissue shows nodular cirrhosis, focal intrahepatic bile duct hyperplasia. Immunohistochemistry: -Slide 4: Hepatocyte(+), CD34(capillarization), Glypican-3(+), AFP(-), GS-6(diffusely+), Arginase-1(+). -Slide 9: CK19(bile ducts+), Ki67(index 1%+)."
66,"(Enlarged right anterior liver lobe) Multiple hepatocellular carcinomas (two lesions, the largest measuring 4.5x3x2.7 cm, Edmondson-Steiner grade II-III; the smaller measuring 2x1.5x1.2 cm, Edmondson-Steiner grade II), vascular tumor thrombus visible (MVI: M1), no nerve invasion, no liver capsule involvement, resection margin is negative, surrounding liver tissue shows nodular cirrhosis. Immunohistochemistry: Hepatocyte(+), GS-6(+), Glypican-3(+), Arginase-1(focally+), CD34(capillarization), AE1/AE3(+), Vimentin(-), CD10(focally+), CAIX(-), PAX-8(-). Gallbladder with multiple cholesterol polyps, chronic cholecystitis, gallbladder adenomyomatosis, cervical lymph node without abnormalities (0/1)."
67,"(Right liver biopsy) Hepatocellular carcinoma (Edmondson-Steiner grade III). AE1/AE3(+), Hept1(focal+), CD34(capillarization+), GS(+), Glypican-3(+), Ki67(60%+), Arginase-1(+), CK19(-)."
68,"(Liver biopsy) Moderately differentiated hepatocellular carcinoma, with extensive necrosis. Immunohistochemistry: AE1/AE3(+), Hepatocyte(+), CD10(-), CK8/18(+), GS-6(+), GPC3(+), Arg1(-), CD34(-), PDL1(22C3: TPS -)."
69,"(Liver biopsy) Well-differentiated hepatocellular carcinoma (Edmondson-Steiner grade II). Immunohistochemistry: AE1/AE3(+), Vimentin(-), Hept1(+), Arginase-1(+), GS-6(+), Glypican-3(+), CD34(capillarization), Ki67(approximately 30), PDL1(5%+)."
70,"(1. Left liver mass) Hepatocellular carcinoma (Edmondson-Steiner grade II-III), no nerve invasion, vascular tumor thrombus visible adjacent to the tumor (MVI: M1), involving the liver capsule (without breakthrough), resection margin is negative, surrounding liver tissue shows nodular cirrhosis. Immunohistochemistry: AE1/AE3(+), Vimentin(-), Hept1(+), Glypican-3(+), GS-6(+), CD34(capillarization), Arg1(+), CK19(-)."
71,"(Right liver nodule biopsy) Hepatocellular carcinoma (moderately differentiated). Immunohistochemistry: AE1/AE3(+), Hepatocyte(+), Glypican-3(+), AFP(+), Arginase-1(+), GS-6(+), CK19(-), CK7(-), Vimentin(-)."
72,"(Right liver low echo nodule biopsy) Hepatocellular carcinoma (moderately to well differentiated). Immunohistochemistry: AE1/AE3(+), Hepatocyte(+), Glypican-3(+), Arginase-1(+), GS-6(+), PDL1(-), Vimentin(-)."
73,"(Left liver biopsy) Hepatocellular carcinoma (well differentiated). Immunohistochemistry: AFP(+), Ki67(30%+), CD34(vascular+), CDX-2(-), S-100P(-), CD10(-), Glypican-3(+), Hepatocyte(partially+), Arginase-1(-), GS-6(+)."
74,"(Liver biopsy) Well-differentiated hepatocellular carcinoma. Immunohistochemistry: AE1/AE3(+), Vimentin(-), TTF-1(-), NapsinA(-), CD56(-), Syn(-), CgA(-), Ki67(10%+), Hepatocyte(+), Arg1(-), GS(+), Villin(+), CK7(-), CK19(-)."
75,"(Right liver mass biopsy) The morphology and immunohistochemistry results are consistent with moderately differentiated hepatocellular carcinoma. Immunohistochemistry: Hepatocyte(+), Arginase-1(+), Glypican-3(+), GS-6(+), CD34(capillarization), CD10(-), AFP(-), Vimentin(-), PDL1(-), PDL1(negative control, -)."
76,"(Right liver low echo nodule biopsy) Hepatocellular carcinoma (moderately differentiated). Immunohistochemistry: AE1/AE3(+), Hepatocyte(+), Glypican-3(+), Arginase-1(+), CK19(-), CK20(-), Vimentin(-), CK7(-), CK5/6(-), GATA3(-), PSA(-), Syn(-), CD56(-), NSE(-), TTF-1(-)."
77,"(Right liver biopsy) Moderately differentiated hepatocellular carcinoma (Edmondson-Steiner grade III), with focal neuroendocrine differentiation. Immunohistochemistry: GS-6(+), Arginase-1(-), Hepatocyte(-), Glypican-3(-), AE1/AE3(+), Vimentin(-), Ki67(80%+), CK5/6(-), Syn(focal+), CD34(vascular+)."
78,"(Left outer liver) Well-differentiated hepatocellular carcinoma (Edmondson-Steiner grade I), no vascular tumor thrombus, no invasion of the liver capsule, resection margin is clear, surrounding and adjacent liver tissue shows cirrhosis. Immunohistochemistry: AE1/AE3(+), Hepatocyte(+), CEA(-), CD10(focal+), CK8/18(+), GS-6(+), GPC3(+), CD34(capillarization+), Ki67(approximately 5%+), Arg1(+). Chronic cholecystitis."
79,"(Left inner liver biopsy) Hepatocellular carcinoma (moderately differentiated). Immunohistochemistry: AE1/AE3(+), Arginase-1(-), Hepatocyte(+), GS-6(+), CD34(capillarization+), Glypican-3(focally+), CK8/18(+), CD10(+), PDL1(22c3; TPS-)(negative control, -)."
80,"(Right liver tumor biopsy) Morphology and immunohistochemistry results are consistent with hepatocellular carcinoma with patchy necrosis. Immunohistochemistry: Hepatocyte(focal+), CK19(+), Glypican-3(+), CD34(capillarization), GS-6(+), Ki67(index 20%+), PDL1(-), PDL1(negative control: -), TTF-1(-), P40(-)."
81,"(Right liver mass) Moderately differentiated hepatocellular carcinoma (Edmondson-Steiner grade II), no nerve invasion, with vascular cancer thrombus (MVI grade M2, thrombus completely necrotic), no liver capsule or resection margin involvement, surrounding liver tissue shows nodular cirrhosis. Immunohistochemistry: Hepatocyte(+), Glypican-3(-), GS-6(+), Arginase-1(+), CD34(capillarization), CDX-2(-), PD-L1(-), PD-1(-)."
82,"(Right liver biopsy) Hepatocellular carcinoma (moderately differentiated), with patchy necrosis. Immunohistochemistry: AE1/AE3(+), Glypican-3(+), GS(partially+), Arg1(focal+), Vimentin(-), Hept1(-), CD34(capillarization), TTF-1(-)."
83,"(Liver) Few hepatocellular carcinoma cells (moderately differentiated). Immunohistochemistry: Hepatocyte(+), CD10(+), GS(+), Glypican-3(+), Arginase-1(+), AFP(-), Ki67(50%+), PD-L1(-), CD34(vascular+)."
84,"(Right liver) Moderately differentiated hepatocellular carcinoma (Edmondson-Steiner grade II), with regional necrosis, local liver capsule invasion (not penetrated), visible portal vein thrombus, no nerve invasion, cirrhosis around the tumor, no cancer at the resection margin. Focal area showing moderately differentiated adenocarcinoma (flat area 1.3x0.3CM), suspected mixed hepatocellular-cholangiocarcinoma, clinical correlation recommended. Immunohistochemistry: AE1/AE3(+), CK7(adenocarcinoma+), CK20(adenocarcinoma+), CDX-2(-), Villin(+), Hepatocyte(+), CD10(+), GS-6(-), GPC3(focal+), CD34(capillarization+), CK19(adenocarcinoma+), PD-L1(22C3: negative, approximately 5% of tumor cell membranes show immune reactivity). Chronic cholecystitis, (Gallbladder neck) reactive lymph node hyperplasia."
85,"(Right liver biopsy) Poorly differentiated carcinoma, with morphology and immunohistochemistry suggesting hepatocellular carcinoma, vascular invasion noted. Immunohistochemistry: AE1/AE3(+), GS-6(+), CK19(+), CK7(+), Vimentin(-), GPC3(-), Hepatocyte(-), Arginase-1(-), CK5/6(-), TTF-1(-), CEA(-)."
86,"(Right liver biopsy) Few hepatocellular carcinoma cells with patchy necrosis. Immunohistochemistry: Hepatocyte(-), Glypican-3(+), CD34(capillarization), GS-6(+), Ki67(approximately 70%+), TTF-1(-), CK8/18(+), CK19(-), PD-L1(CPS: 3%), PD-L1(negative control: -)."
87,"(Liver lesion biopsy) Hepatocellular carcinoma (Edmondson-Steiner grade III). Immunohistochemistry: AE1/AE3(+), Hepatocyte(+), Arg1(+), Glypican-3(+), CD34(capillarization), GS-6(+), Ki67(10%+), CK19(-), Vimentin(mesenchymal tissue+), CK7(-)."
88,"(Right liver biopsy) Hepatocellular carcinoma (moderately differentiated). Immunohistochemistry: Hepatocyte(+), Glypican-3(+), Arg1(+), GS-6(+), CD34(capillarization+), CK8/18(+), CK19(-), Ki67(index 50%+), PD-L1(CPS score = 2)."
89,"(Liver biopsy) Hepatocellular carcinoma (moderately differentiated). Immunohistochemistry: Glypican-3(+), Arginase-1(-), GS(+), Ki67(2+), CD34(vascular+), CD10(+), Hepatocyte(-), AFP(-), CDX-2(-), S-100P(-)."
90,"(Seventh rib biopsy) Metastatic hepatocellular carcinoma. Immunohistochemistry: CD34(vascular+), Glypican-3(+), GS-6(+), Hepatocyte(scattered+), CD10(+), AE1/AE3(+), CK8/18(+), CEA(-), AFP(-), Ki67(approximately 40%+)."
91,"(Liver right lobe solid mass biopsy): Residual small foci of degenerative atypical cells at the edge of necrosis, combined with immunohistochemistry, consistent with hepatocellular carcinoma. Immunohistochemistry: Hepatocyte (-), Glypican-3 (+), GS-6 (focal +), Arginase-1 (-), PDL1 (1%+), PD-1 (-)."
92,"(Liver biopsy): Hepatocellular carcinoma (moderate differentiation). Immunohistochemistry: Hept1 (+), CD34 (sinusoidal capillarization), AE1/AE3 (+), Arg1 (+), AFP (+), GS-6 (+), Glypican-3 (+), CK19 (+), CK7 (-), Vimentin (-), PDL1 (-)."
93,"(Liver right lobe): Hepatocellular carcinoma (trabecular type, Edmondson-Steiner grade III) with necrosis, vascular tumor thrombus (MVI: M2), and satellite nodules. No nerve invasion; liver capsule rupture with hemorrhage. Surgical margins are tumor-free. Immunohistochemistry: AE1/AE3 (+), Vim (mesenchymal +), Hep1 (-), Arginase-1 (+), GS-6 (weak +), CD34 (vascular +), CK19 (-), Syn (-), Ki67 (60%+), Glypican-3 (+)."
94,"(Liver right lobe biopsy): Hepatocellular carcinoma (moderate differentiation, Edmondson-Steiner grade III). Immunohistochemistry: AE1/AE3 (+), Vimentin (mesenchymal +), Hepatocyte (+), CD34 (sinusoidal capillarization), Arg1 (+), Glypican-3 (-), GS-6 (+), CK19 (-), PDL1 (22c3, CPS: 10)."
95,"(Liver): Hepatocellular carcinoma (moderate differentiation, Edmondson-Steiner grade II), vascular invasion (MVI: M2), no nerve invasion or satellite lesions, close to the liver capsule, surgical margins tumor-free. Surrounding liver shows nodular cirrhosis. Immunohistochemistry: Hepatocyte (+), Glypican-3 (+), Arginase-1 (+), GS-6 (+), CD34 (sinusoidal capillarization), AFP (-), PD-1 (-), PDL1 (-, control shows good). (Note: PD-L1 clone: 22C3; VENTANA BenchMark Ultra)."
96,"(Liver right lobe biopsy): Hepatocellular carcinoma (moderate differentiation). Immunohistochemistry: AE1/AE3 (+), Hepatocyte (+), Arginase-1 (+), Glypican-3 (+), Ki67 (25%+), PDL1 (negative; 5% of tumor cells showing immune response), GS-6 (+), CD34 (vascular +), CD10 (-), CK8/18 (+)."
97,"(Liver right lobe biopsy): Hepatocellular carcinoma; Immunohistochemistry: Hepatocyte (+), Arg1 (focal +), CK7 (scattered +), CK19 (focal +), CDX-2 (-), Glypican-3 (+), CEA (-), TTF-1 (-), CD34 (sinusoidal capillarization), GS-6 (+)."
98,"(Liver left lobe mass biopsy): Hepatocellular carcinoma (moderate differentiation). Immunohistochemistry: AE1/AE3 (+), Arginase-1 (+), Hepatocyte (focal +), GS-6 (+), Glypican-3 (+), CD34 (sinusoidal capillarization), Ki67 (60%+), Vimentin (-), CDX-2 (-), CK19 (-)."
99,"(Liver segment 6): Hepatocellular carcinoma (moderate differentiation, Edmondson-Steiner grade III), no nerve invasion or vascular tumor thrombus (MVI: M0), liver capsule intact, surgical margins tumor-free, surrounding liver shows nodular cirrhosis. (Liver segment 7): Nodular cirrhosis. Liver segment 6: AE1/AE3 (+), Vimentin (-), CD34 (sinusoidal capillarization), Hepatocyte (+), GS-6 (+), Glypican-3 (+), Arginase-1 (+)."
100,"(Liver right lobe biopsy): Hepatocellular carcinoma (Edmondson-Steiner grade III). Immunohistochemistry: AE1/AE3 (+), Vimentin (mesenchymal +), Arginase-1 (+), Hepatocyte (+), Glypican-3 (+), CD34 (sinusoidal capillarization), CK19 (-), CK7 (-), CK20 (-), CDX-2 (-), Villin (+)."
